These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. IGF-1 alleviates serum IgG-induced neuronal cytolysis through PI3K signaling in children with opsoclonus-myoclonus syndrome and neuroblastoma. Ding X, Han W, Wang J, Yang W, Chang XF, Zhu ZY, Qin H, Zhang JZ, Wang X, Wang HM. Pediatr Res; 2019 May; 85(6):885-894. PubMed ID: 30718793 [Abstract] [Full Text] [Related]
3. NK Cell-mediated Neuroblastoma Cell Lysis is Enhanced by IgG From Patients With Pediatric Opsoclonus-Myoclonus Syndrome. Zar T, Tschernatsch M, Hero B, Lang B, Preissner KT, Blaes F. J Pediatr Hematol Oncol; 2021 Mar 01; 43(2):e176-e179. PubMed ID: 33060390 [Abstract] [Full Text] [Related]
6. Multifactorial analysis of opsoclonus-myoclonus syndrome etiology ("Tumor" vs. "No tumor") in a cohort of 356 US children. Pranzatelli MR, Tate ED, McGee NR. Pediatr Blood Cancer; 2018 Aug 01; 65(8):e27097. PubMed ID: 29727049 [Abstract] [Full Text] [Related]
12. IgG subclass distribution of autoantibodies in pediatric opsoclonus-myoclonus syndrome. Beck S, Fühlhuber V, Krasenbrink I, Tschernatsch M, Kneifel N, Kirsten A, Jaeger C, Kaps M, Preissner KT, Lang B, Rostasy K, Blaes F. J Neuroimmunol; 2007 Apr 15; 185(1-2):145-9. PubMed ID: 17324472 [Abstract] [Full Text] [Related]
13. Elevated B-cell activating factor BAFF, but not APRIL, correlates with CSF cerebellar autoantibodies in pediatric opsoclonus-myoclonus syndrome. Fühlhuber V, Bick S, Kirsten A, Hahn A, Gerriets T, Tschernatsch M, Kaps M, Preissner KT, Blaes F, Altenkämper S. J Neuroimmunol; 2009 May 29; 210(1-2):87-91. PubMed ID: 19339060 [Abstract] [Full Text] [Related]
14. The bradykinin-cGMP-PKG pathway augments insulin sensitivity via upregulation of MAPK phosphatase-5 and inhibition of JNK. Frigolet ME, Thomas G, Beard K, Lu H, Liu L, Fantus IG. Am J Physiol Endocrinol Metab; 2017 Sep 01; 313(3):E321-E334. PubMed ID: 28679626 [Abstract] [Full Text] [Related]
15. Microglial activation and the nitric oxide/cGMP/PKG pathway underlie enhanced neuronal vulnerability to mitochondrial dysfunction in experimental multiple sclerosis. Mancini A, Tantucci M, Mazzocchetti P, de Iure A, Durante V, Macchioni L, Giampà C, Alvino A, Gaetani L, Costa C, Tozzi A, Calabresi P, Di Filippo M. Neurobiol Dis; 2018 May 01; 113():97-108. PubMed ID: 29325869 [Abstract] [Full Text] [Related]
19. Embryonic motor neuron dendrite growth is stunted by inhibition of nitric oxide-dependent activation of soluble guanylyl cyclase and protein kinase G. Xiong G, Mojsilovic-Petrovic J, Pérez CA, Kalb RG. Eur J Neurosci; 2007 Apr 01; 25(7):1987-97. PubMed ID: 17439487 [Abstract] [Full Text] [Related]
20. Opsoclonus-myoclonus Syndrome with Neuroblastoma in Children and their Anaesthetic Management. Gupta A, Kundal R, Pandey M. J Coll Physicians Surg Pak; 2022 Aug 01; 32(8):1086-1088. PubMed ID: 35932142 [Abstract] [Full Text] [Related] Page: [Next] [New Search]